Overview

This strain has been discontinued, please refer to Stock No. 002902 STOCK Pax3^Sp Mlph^ln/J.

Genetic overview

Genetic Background	Generation

Pax3^Sp

Allele Type	Gene Symbol	Gene Name
Spontaneous	Pax3	paired box 3

View Genetics

Research Applications

Mouse/Human Gene Homologs
Dermatology Research
Developmental Biology Research
Neurobiology Research

View All Research Applications

Details

Detailed Description

Mice homozygous for the splotch spontaneous mutation (Pax3^Sp) die at E13 due to neural tube defects. Malformations of homozygous mutant embryos include rachischisis in the lumbosacral region and frequently in the region of the hindbrain. Heterozygous splotch mice show white spotting on the belly and occasionally on the back, feet, and tail. Splotch is a point mutation within intron 3 of the paired homeobox 3 (Pax3) gene on mouse Chromosome 1. The mutation interferes with normal splicing of intron 3 and leads to at least 4 aberrantly spliced mRNAs with exon 4 deleted. The Pax3^Sp mutation also impairs homodimerization of the protein, a function associated with the octapeptide-encoding central segment of the gene. There are multiple alleles at this locus including splotch-delayed (Pax3^Sp-d, Stock No. 000565), which is similar to splotch but displays caudal rachischisis only.

Genetics

Pax3^Sp

Allele Symbol: Pax3^Sp

Allele Name	splotch
Allele Type	Spontaneous
Allele Synonym(s)	Sp
Gene Symbol and Name	Pax3, paired box 3
Gene Synonym(s)
Strain of Origin	C57BL
Chromosome	1
Molecular Note	The mutation comprises the replacement of TCTCCA with CGTGT at the 3' end of intron 3. Since the CA dinucleotide at the end is part of the exon 4 CAG splice acceptor site, this splice site is eliminated in this allele, having been changed to GTG. This mutation abrogates the normal splicing of intron 3, resulting in the generation of four aberrantly spliced mRNA transcripts. Two of these Pax-3 transcripts make use of cryptic 3' splice sites within the downstream exon, generating small deletions which disrupt the reading frame of the transcripts. A third aberrant splicing event results in the deletion of exon 4, while a fourth retains intron 3. These aberrantly spliced mRNA transcripts are not expected to result in functional Pax3 proteins.

Disease/Phenotype

Disease Terms

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: Pax3^Sp related

Mouse/Human Gene Homologs
- Waardenburg syndrome, type I
Dermatology Research
- Color and White Spotting Defects
Developmental Biology Research
- Neural Crest Defects
- Neural Tube Defects
Neurobiology Research
- Neural Tube Defects

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Pax3^Sp/Pax3^Sp
C57BL-Pax3

cellular phenotype

increased mitotic index
- at E10 and 11, mesencephalic ventricular cells have increased mitotic index compared to wild-type

integument phenotype

absent coat pigmentation
- embryonic tissue explants allowed to develop until hair is formed display well developed hairs that are devoid of pigment

absent skin pigmentation
- embryonic tissue explants allowed to develop until the time when pigment would normally form are devoid of pigment

limbs/digits/tail phenotype

abnormal tail morphology
- distorted shape correlated to degree of rachischisis and neural overgrowth
- hematomas are frequently found in regions of tail curvature

kinked tail

mortality/aging

lethality throughout fetal growth and development, complete penetrance
- die around E14

nervous system phenotype

abnormal brain ventricle morphology
- at E10 or later, the lumen of the brain is highly distorted and partially collapsed or obliterated by the excessive overgrowth of neural tissue
- the lumen in the region of the myelencephalon and rhombencephalon are most sevely affected

abnormal dorsal root ganglion morphology
- in the region of the anterior limb buds spinal ganglia are absent or greatly reduced in size, disorganized, and abnormally located on the dorsal part of the neural tube
- the lumbo-sacral region spinal ganglia are usually absent

abnormal midbrain development
- at E10 and E11, mesencephalic ventricular cells display increased generation time, increased mitotic index, and prolonged mitosis, S phase, and G1
- the lumen in the mesencephalic region is greatly reduced and obscured by neural tissue

abnormal neural tube morphology
- neural overgrowth occurs laterad from the mid-dorsal line of the neural folds
- overgrowth of neural tissue in the region of the open neural tube is variable and becomes more pronounced with age
- ventricular cells in the upper lumbar neural tube and lower lumbar and sacral neural groove contain many gap junctional vesicles that are rarely seen in wild-type or heterozygous mice

open neural tube
- at E10 - E12.5, the extent to which the neural fold are open is highly variable ranging from just a small area in the lumbo-sacral region up to from the lumbo-sacral region to the tip of the tail
- at E9.5, neural folds are open in the hindlimb region with aggregation of neural tissue on both sides of the dorsal midline
- open neural folds generally limited to the hindbrain region are seen in about 56% of mice at E10, these are always associated with overgrowth of neural tissue
- open neural folds in the hindbrain region
- the extent of the area of open neural tube tends to increase in proportion to growth of the embryo

small embryonic telencephalon
- vesicles appear as a network of small channels

spina bifida

embryo phenotype

abnormal neural tube morphology
- neural overgrowth occurs laterad from the mid-dorsal line of the neural folds
- overgrowth of neural tissue in the region of the open neural tube is variable and becomes more pronounced with age
- ventricular cells in the upper lumbar neural tube and lower lumbar and sacral neural groove contain many gap junctional vesicles that are rarely seen in wild-type or heterozygous mice

open neural tube
- at E10 - E12.5, the extent to which the neural fold are open is highly variable ranging from just a small area in the lumbo-sacral region up to from the lumbo-sacral region to the tip of the tail
- at E9.5, neural folds are open in the hindlimb region with aggregation of neural tissue on both sides of the dorsal midline
- open neural folds generally limited to the hindbrain region are seen in about 56% of mice at E10, these are always associated with overgrowth of neural tissue
- open neural folds in the hindbrain region
- the extent of the area of open neural tube tends to increase in proportion to growth of the embryo

spina bifida

pigmentation phenotype

absent coat pigmentation
- embryonic tissue explants allowed to develop until hair is formed display well developed hairs that are devoid of pigment

absent skin pigmentation
- embryonic tissue explants allowed to develop until the time when pigment would normally form are devoid of pigment

Genotype: Pax3^Sp/Pax3⁺
C57BL-Pax3

integument phenotype

belly spot

white spotting
- occasional spotting on the back and increased spotting on the tail compared to wild-type mice
- the feet are usually white

pigmentation phenotype

belly spot

white spotting
- occasional spotting on the back and increased spotting on the tail compared to wild-type mice
- the feet are usually white

Genotype: Pax3^Sp/Pax3^Sp
involves: C57BL

cellular phenotype

abnormal muscle precursor cell migration
- DiI injections into the 3 somites immediately adjacent to the forelimb bud between E9.25 and E9.5 reveal impaired cell migration with no cell moving more than 30 - 40 um from the site of injection

mortality/aging

embryonic lethality during organogenesis, complete penetrance
- die around E13-E14
- Background Sensitivity - mice die earlier compared to homozygotes on a congenic C57BR background

muscle phenotype

abnormal dermomyotome development
- at E9.25, premature termination of the dermamyotome at the same level as the ventral lip of the axial myotome with absence of any epithelial structure in the ventral portion
- foreshortening of the epaxial domain and complete loss of the hypaxial domain of the dermomyotome at E10.5

abnormal hypoglossal cord morphology
- lack myogenic cells in the hypoglossal cord at E11.5

abnormal muscle precursor cell migration
- DiI injections into the 3 somites immediately adjacent to the forelimb bud between E9.25 and E9.5 reveal impaired cell migration with no cell moving more than 30 - 40 um from the site of injection

abnormal myogenesis
- at E10.5 Pax3 expressing cells are absent from the forelimb and hindlimb buds
- at E12.5 expression of muscle specific markers myogenin and acetylcholinesterase are absent from the forelimb buds and expression of acetylcholinesterase is also absent from the hindlimb buds
- however, cells from somites grafted into chick limbs are able to undergo myogenic differentiation
- lack myogenic cells in the forming limb buds and hypoglossal cord at E11.5
- limb buds from E11 embryos cultured for 4 days fail to generate any cells expressing early myogenic markers (desmin and sarcomeric myosin)

craniofacial phenotype

abnormal bony labyrinth
- all labyrinth structures are abnormal in mice where the neural tube defect extend into the cranial region; however in mice with only sacro-caudal neural tube defects ear morphology is normal

nervous system phenotype

open neural tube
- 10 of 13 had open neural tube in sacro-caudal and cranial regions while in the other 3 the defect was confined to the sacro-caudal region

spina bifida
- treatment with folate solution of heterozygous females crossed to heterozygous males results in 40% decrease in spina bifida incidence in homozygous embryos examined at midgestation

skeleton phenotype

abnormal bony labyrinth
- all labyrinth structures are abnormal in mice where the neural tube defect extend into the cranial region; however in mice with only sacro-caudal neural tube defects ear morphology is normal

embryo phenotype

open neural tube
- 10 of 13 had open neural tube in sacro-caudal and cranial regions while in the other 3 the defect was confined to the sacro-caudal region

spina bifida
- treatment with folate solution of heterozygous females crossed to heterozygous males results in 40% decrease in spina bifida incidence in homozygous embryos examined at midgestation

hearing/vestibular/ear phenotype

abnormal bony labyrinth
- all labyrinth structures are abnormal in mice where the neural tube defect extend into the cranial region; however in mice with only sacro-caudal neural tube defects ear morphology is normal

abnormal endolymphatic duct morphology
- at E10, the origin of endolymphatic duct is shifted backwards and upwards and the duct is shorter and conical in shape
- at E11 the duct extends backwards and outwards rather than vertically upwards as in wild-type mice

abnormal otic vesicle development
- in mice where the neural tube defect extends to the cranial region

abnormal semicircular canal morphology
- present but abnormally located in terms of their planes, point of origin, and relationship to other structures in the labyrinth

abnormal utricle morphology
- difficult to distinguish and highly abnormal

abnormal vestibular saccule morphology
- difficult to distinguish and highly abnormal

decreased cochlear coiling
- at E12 cochlear coiling is poor

short endolymphatic duct
- at E10, the endolymphatic duct is shorter than normal

Genotype: Pax3^Sp/Pax3^Sp
BR.B-Pax3

embryo phenotype

spina bifida cystica
- spina bifida aperta in the lumbosacral area

mortality/aging

perinatal lethality, complete penetrance
- die around E18-E19
- Background Sensitivity - mice die later compared to mice on a mixed genetic background that includes C57BL

nervous system phenotype

spina bifida cystica
- spina bifida aperta in the lumbosacral area

Genotype: Pax3^Sp/Pax3⁺
involves: C3HeB * C57BL * C57BL/6J * SWV

embryo phenotype

spina bifida
- increased incidence of spina bifida induced by in utero exposure to 50 mg/kg trans-retinoic acid compared to treated wild-type littermates

nervous system phenotype

spina bifida
- increased incidence of spina bifida induced by in utero exposure to 50 mg/kg trans-retinoic acid compared to treated wild-type littermates

Genotype: Pax3^Sp/Pax3⁺
involves: C57BL * C57BL/6J * CBA

mammalian phenotype

hearing/vestibular/ear phenotype
- auditory function and ear morphology are similar to wild type mice
- Normal - auditory function and ear morphology are similar to wild-type mice

Genotype: Pax3^Sp/Pax3^Sp
involves: 129S2/SvPas * C57BL * C57BL/6J * FVB

cellular phenotype

increased embryonic neuroepithelium apoptosis
- many apoptotic neuroepithelial cells seen at the site of the neural tube defect

embryo phenotype

open neural tube
- seen in all mice
- treatment with pifithrin-alpha from E8.5 to E9.5 prevented neural tube defects in 55% of embryos

nervous system phenotype

increased embryonic neuroepithelium apoptosis
- many apoptotic neuroepithelial cells seen at the site of the neural tube defect

open neural tube
- seen in all mice
- treatment with pifithrin-alpha from E8.5 to E9.5 prevented neural tube defects in 55% of embryos

References

Additional References

Brown CB; Feiner L; Lu MM; Li J; Ma X; Webber AL; Jia L; Raper JA; Epstein JA. 2001. PlexinA2 and semaphorin signaling during cardiac neural crest development. Development 128(16):3071-80PubMed: 11688557 MGI: J:71241
Chalepakis G; Goulding M; Read A; Strachan T; Gruss P. 1994. Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc Natl Acad Sci U S A 91(9):3685-9PubMed: 7909605 MGI: J:18260
Epstein DJ; Vekemans M; Gros P. 1991. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67(4):767-74PubMed: 1682057 MGI: J:2944
Epstein DJ; Vogan KJ; Trasler DG; Gros P. 1993. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci U S A 90(2):532-6PubMed: 8421686 MGI: J:3731
Epstein JA; Li J; Lang D; Chen F; Brown CB; Jin F; Lu MM; Thomas M; Liu E; Wessels A; Lo CW. 2000. Migration of cardiac neural crest cells in Splotch embryos. Development 127(9):1869-78PubMed: 10751175 MGI: J:61431
Ernest S; Christensen B; Gilfix BM; Mamer OA; Hosack A; Rodier M; Colmenares C; McGrath J; Bale A; Balling R; Sankoff D; Rosenblatt DS; Nadeau JH. 2002. Genetic and molecular control of folate-homocysteine metabolism in mutant mice. Mamm Genome 13(5):259-67PubMed: 12016514 MGI: J:76559
Goulding M; Sterrer S; Fleming J; Balling R; Nadeau J; Moore KJ; Brown SD; Steel KP; Gruss P. 1993. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17(2):355-63PubMed: 8406486 MGI: J:13559
Helmbacher F; Dessaud E; Arber S; deLapeyriere O; Henderson CE; Klein R; Maina F. 2003. Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools. Neuron 39(5):767-77PubMed: 12948444 MGI: J:85300
Houzelstein D; Cheraud Y; Auda-Boucher G; Fontaine-Perus J; Robert B. 2000. The expression of the homeobox gene Msx1 reveals two populations of dermal progenitor cells originating from the somites. Development 127(10):2155-64PubMed: 10769239 MGI: J:61521
Mansouri A; Stoykova A; Gruss P. 1994. Pax genes in development. J Cell Sci Suppl 18:35-42PubMed: 7883790 MGI: J:24468
Potterf SB; Mollaaghababa R; Hou L; Southard-Smith EM; Hornyak TJ; Arnheiter H; Pavan WJ. 2001. Analysis of sox10 function in neural crest-derived melanocyte development: sox10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 237(2):245-57PubMed: 11543611 MGI: J:71587
Walther C; Guenet JL; Simon D; Deutsch U; Jostes B; Goulding MD; Plachov D; Balling R; Gruss P. 1991. Pax: a murine multigene family of paired box-containing genes. Genomics 11(2):424-34PubMed: 1685142 MGI: J:11577

Additional - Pax3^Sp related

Technical Support

CONTACT TECHNICAL SUPPORT

Genotyping Protocols
- Genotyping resources and troubleshooting
Appearance
- black with white spotting
  Related Genotype: a/a Pax3^Sp/+

Terms Of Use

General Terms and Conditions

Questions about Terms of Use

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Genetic overview

Research Applications

Detailed Description

Pax3Sp

Allele Symbol: Pax3Sp

Disease Terms

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Genotype: Pax3Sp related

Mammalian Phenotype Terms by Genotype

Genotype: Pax3Sp/Pax3SpC57BL-Pax3

cellular phenotype

integument phenotype

limbs/digits/tail phenotype

mortality/aging

nervous system phenotype

embryo phenotype

pigmentation phenotype

Genotype: Pax3Sp/Pax3+C57BL-Pax3

integument phenotype

pigmentation phenotype

Genotype: Pax3Sp/Pax3Spinvolves: C57BL

cellular phenotype

mortality/aging

muscle phenotype

craniofacial phenotype

nervous system phenotype

skeleton phenotype

embryo phenotype

hearing/vestibular/ear phenotype

Genotype: Pax3Sp/Pax3SpBR.B-Pax3

embryo phenotype

mortality/aging

nervous system phenotype

Genotype: Pax3Sp/Pax3+involves: C3HeB * C57BL * C57BL/6J * SWV

embryo phenotype

nervous system phenotype

Genotype: Pax3Sp/Pax3+involves: C57BL * C57BL/6J * CBA

mammalian phenotype

Genotype: Pax3Sp/Pax3Spinvolves: 129S2/SvPas * C57BL * C57BL/6J * FVB

cellular phenotype

embryo phenotype

nervous system phenotype

References

Additional References

Additional - Pax3Sp related

Genotyping Protocols

Appearance

Terms Of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Pax3^Sp

Allele Symbol: Pax3^Sp

Genotype: Pax3^Sp related

Genotype: Pax3^Sp/Pax3^Sp
C57BL-Pax3

Genotype: Pax3^Sp/Pax3⁺
C57BL-Pax3

Genotype: Pax3^Sp/Pax3^Sp
involves: C57BL

Genotype: Pax3^Sp/Pax3^Sp
BR.B-Pax3

Genotype: Pax3^Sp/Pax3⁺
involves: C3HeB * C57BL * C57BL/6J * SWV

Genotype: Pax3^Sp/Pax3⁺
involves: C57BL * C57BL/6J * CBA

Genotype: Pax3^Sp/Pax3^Sp
involves: 129S2/SvPas * C57BL * C57BL/6J * FVB

Additional - Pax3^Sp related